Search

Search Results

• OC-14 | Efficacy of eptinezumab during a migraine attack: preliminary data from an Italian multicenter real-world experience (the BEFREE study) Luisa Fofi,¹ Claudia Altamura,¹ Marilena Marcosano,¹ Alberto Doretti,² Francesca Pistoia,³ Antonio Granato,⁴ Simona Guerzoni,⁵ Michele Trimboli,⁶ Licia Grazzi,⁷ Danilo Antonio Montisano,⁷ Gianluca Avino,⁸ Gabriele Sebastianelli,⁹ Carla Fasano,¹⁰ Elisa Maria Piella,¹¹ Nicoletta Brunelli,¹ Luigi Francesco Iannone,^5,12 Fabrizio Vernieri¹ on behalf of the Italian Headache Registry (RICe) Study Group | ¹Neurosonology and Headache Unit, Fondazione Policlinico Campus Bio-Medico, Rome; ²IRCCS Istituto Auxologico Italiano - Department of Neurology and Laboratory of Neuroscience - Milan; ³University of L’Aquila; ⁴Headache Center, Neurology Clinic, University of Trieste, University Hospital of Trieste; ⁵AOU Policlinico di Modena; ⁶Azienda Ospedaliera-universitaria "Renato Dulbecco", Catanzaro; ⁷Headache Center, Neuroalgology Dpt, IRCCS Foundation "Carlo Besta" Neurological Institute, Milan; ⁸SOC Neurologia, Ospedale Santo Stefano, USL Toscana Centro, Prato; ⁹La Sapienza University of Rome Polo Pontino, Latina; ¹⁰Headache and Cerebrovascular Diseases Center, Neurology Unit 2, Careggi University Hospital, Florence; ¹¹Department of Neuroscience “Rita Levi Montalcini”, University of Turin; ¹²Università di Modena e Reggio Emilia, Italy

  Società Italiana per lo Studio delle Cefalee (SISC)

  06-11-2025

  https://doi.org/10.4081/cc.2025.15811

  327